AU3744397A - Total synthesis of antitumor acylfulvenes - Google Patents

Total synthesis of antitumor acylfulvenes

Info

Publication number
AU3744397A
AU3744397A AU37443/97A AU3744397A AU3744397A AU 3744397 A AU3744397 A AU 3744397A AU 37443/97 A AU37443/97 A AU 37443/97A AU 3744397 A AU3744397 A AU 3744397A AU 3744397 A AU3744397 A AU 3744397A
Authority
AU
Australia
Prior art keywords
acylfulvenes
antitumor
total synthesis
synthesis
total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37443/97A
Other languages
English (en)
Inventor
Trevor C Mcmorris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU3744397A publication Critical patent/AU3744397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/94—Spiro compounds containing "free" spiro atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials
AU37443/97A 1996-08-08 1997-08-05 Total synthesis of antitumor acylfulvenes Abandoned AU3744397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08689461 1996-08-08
US08/689,461 US5723632A (en) 1996-08-08 1996-08-08 Total synthesis of antitumor acylfulvenes
PCT/US1997/013644 WO1998005669A1 (en) 1996-08-08 1997-08-05 Total synthesis of antitumor acylfulvenes

Publications (1)

Publication Number Publication Date
AU3744397A true AU3744397A (en) 1998-02-25

Family

ID=24768581

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37443/97A Abandoned AU3744397A (en) 1996-08-08 1997-08-05 Total synthesis of antitumor acylfulvenes

Country Status (12)

Country Link
US (6) US5723632A (US06252093-20010626-C00030.png)
EP (2) EP0918776B1 (US06252093-20010626-C00030.png)
JP (1) JP4267702B2 (US06252093-20010626-C00030.png)
AT (1) ATE263771T1 (US06252093-20010626-C00030.png)
AU (1) AU3744397A (US06252093-20010626-C00030.png)
CA (1) CA2262648A1 (US06252093-20010626-C00030.png)
DE (1) DE69728544T2 (US06252093-20010626-C00030.png)
DK (1) DK0918776T3 (US06252093-20010626-C00030.png)
ES (1) ES2215234T3 (US06252093-20010626-C00030.png)
HK (1) HK1019878A1 (US06252093-20010626-C00030.png)
PT (1) PT918776E (US06252093-20010626-C00030.png)
WO (1) WO1998005669A1 (US06252093-20010626-C00030.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932553A (en) * 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
US6025328A (en) 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents
US7141603B2 (en) * 1999-02-19 2006-11-28 The Regents Of The University California Antitumor agents
US6635490B1 (en) * 2000-05-25 2003-10-21 Noble Laboratories Procedure for the simultaneous quantitative and qualitative analysis of both flavonoid glycosides and steroidal glycosides
DE60142313D1 (de) * 2000-10-02 2010-07-15 Univ Emory Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen
US7015247B2 (en) * 2000-10-12 2006-03-21 Alvin Guttag Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs
US6436916B1 (en) 2000-10-12 2002-08-20 Alvin Guttag Ibuprofen-aspirin and hydroxymethylacylfulvene analogs
BR0210607B1 (pt) * 2001-06-22 2011-06-28 catalisador de metaloceno, sistema catalìtico para a polimerização de olefina, processos para a polimerização de olefina, e para a preparação de um catalisador e metaloceno, e, composto.
US7718385B2 (en) * 2003-10-17 2010-05-18 The Johns Hopkins University Bioactivation of alkylating agents for cancer treatment
WO2007019308A2 (en) * 2005-08-03 2007-02-15 The Regents Of The University Of California Illudin analogs useful as anticancer agents
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
US20080275016A1 (en) * 2007-05-03 2008-11-06 Arbiser Jack L Fulvene and fulvalene analogs and their use in treating cancers
GB0715576D0 (en) * 2007-08-09 2007-09-19 Syngenta Ltd Novel herbicides
EP2240460A4 (en) * 2008-01-07 2012-02-22 Univ Emory BRANCHED DIEPXYDE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
CN106458922A (zh) 2014-04-10 2017-02-22 Af化学药品有限责任公司 亲和药物共轭物
US11135182B2 (en) 2014-04-10 2021-10-05 Af Chemicals, Llc Affinity medicant conjugates
US10285955B2 (en) 2014-04-10 2019-05-14 Af Chemicals, Llc Affinity medicant conjugate
CN104650160A (zh) * 2015-01-13 2015-05-27 济南大学 卡培他滨关键中间体1,2,3-o-三乙酰基-5-脱氧-d-核糖的合成新方法
MX2021002529A (es) * 2018-09-04 2021-08-11 Lantern Paharma Inc Analogos de illudin, usos de los mismos y metodos para sintetizar los mismos.
US11160807B1 (en) 2018-12-11 2021-11-02 Af Chemicals, Llc Methods, compositions and devices for treating cancer with illudofulvenes
US11591295B2 (en) 2019-11-25 2023-02-28 Af Chemicals Llc Affinity illudofulvene conjugates

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
JPS62234040A (ja) * 1986-04-02 1987-10-14 Kyowa Hakko Kogyo Co Ltd Ｄｃ１０４３物質
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5439936A (en) * 1989-10-03 1995-08-08 The Regents Of The University Of California Method of treating certain tumors using illudin analogs
JPH05503077A (ja) * 1989-10-03 1993-05-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 抗腫瘍剤としてのイルージンアナログ
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
DZ1773A1 (fr) * 1993-04-27 2002-02-17 Smithkline Beecham Corp Antagonistes de récepteurs d'endothéline.
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US5932553A (en) * 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) * 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
US6025328A (en) 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents

Also Published As

Publication number Publication date
US5723632A (en) 1998-03-03
US6469184B2 (en) 2002-10-22
ES2215234T3 (es) 2004-10-01
US6160184A (en) 2000-12-12
WO1998005669A1 (en) 1998-02-12
EP1454890A8 (en) 2004-11-03
CA2262648A1 (en) 1998-02-12
EP1454890A2 (en) 2004-09-08
US20010029303A1 (en) 2001-10-11
DE69728544D1 (de) 2004-05-13
HK1019878A1 (en) 2000-03-03
JP2000515552A (ja) 2000-11-21
US6252093B1 (en) 2001-06-26
US6717017B2 (en) 2004-04-06
JP4267702B2 (ja) 2009-05-27
PT918776E (pt) 2004-07-30
DK0918776T3 (da) 2004-07-12
US5856580A (en) 1999-01-05
EP1454890A3 (en) 2004-11-10
EP0918776B1 (en) 2004-04-07
US20030050495A1 (en) 2003-03-13
ATE263771T1 (de) 2004-04-15
DE69728544T2 (de) 2004-09-16
EP0918776A1 (en) 1999-06-02

Similar Documents

Publication Publication Date Title
AU3744397A (en) Total synthesis of antitumor acylfulvenes
AU1282495A (en) Anthranilic acid derivative
EP1106179A3 (en) Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
HUT66660A (en) Intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
AU4523797A (en) Atherosclerosis treatment
AU3981095A (en) Antifungal sordaridin derivatives
AU2722095A (en) Novel pyrrolocarbazoles
DE69529619D1 (en) Pyrimidinylpyrazolderivate
AU7872798A (en) 16-ene-vitamin D derivatives
EP1034783A4 (en) AMIDE DERIVATIVES
AU3106697A (en) Liposome preparations of indolocarbazole derivatives
AU4843896A (en) Optically active thiazolidinone derivative
EP1203763A3 (de) Beta-Hydroxyalkylamide, Verfahren zu ihrer Herstellung und deren Verwendung
AU6115998A (en) Compositions for treatment or prevention of prostate cancer
AU7649796A (en) Compound gexi
AU7020996A (en) UCK14 compounds
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
AU6663596A (en) One pot synthesis of 2-oxazolidinone derivatives
AU6943796A (en) Compounds UCH 15